Resumen de Analysis of the Direct Cost of Medical and Surgical Care for Testicular Cancer in Early and Advanced Stages in a Third Level Medical Facility of the Mexican Social Security Institute

Álvaro José Montiel Jarquín, Margarita Vargas Huerta, Sandra Maldonado Castañeda, Arturo García Galicia, Sebastián Ibarra Zamarrón, Jorge Loría Castellanos

• español

  Objetivo: Comparar los costes directos de atención médica y quirúrgica del cáncer testicular en etapa temprana y avanzada en un hospital de tercer nivel.

  Material y Métodos: Estudio de proceso, se evalúan costes directos de atención médica. Se analizaron número de estudios de laboratorio, gabinete y tratamiento médico y quirúrgico. Los pacientes se dividieron en 2 grupos: grupo 1 estadios tempranos y grupo 2 estadios avanzados. Se utilizó la prueba de U de Mann Whitney para diferencia entre grupos.

  Resultados: Fueron 10 pacientes en cada grupo, Grupo 1: 8 (80%) seminomas y 2 (20%) no seminomas, Grupo 2: 4 (40%) seminomas y 6 (60%) no seminomas. El coste promedio de atención en el Grupo 2 es mayor que en el Grupo 1, $288,827.90 y $145,911.70 pesos mexicanos respectivamente (p=0.00578).

  Conclusiones: El coste directo de atención médica es mayor en los estadios avanzados comparado con los estadios tempranos.

• English

  Background: The testicular cancer prevails in the third decade of life, the care cost increases with higher staging of the disease.

  Objective: Compare the direct costs of medical and surgical attention for testicular cancer in early and advanced stages in a Third Level Medical Facility.

  Material and Methods: Process study, direct costs of medical attention are evaluated. Number of laboratory studies, imaging studies, and medical and surgical treatment were analyzed. The patients were divided into 2 groups: group 1 early stages and group 2 advanced stages. Mann Whitney U test was used for the difference between groups.

  Results: There were 10 patients in each group, Group 1: 8 (80%) seminomas and 2 (20%) non-seminoma, Group 2: 4 (40%) seminomas and 6 (60%) non-seminomas. The average cost of care in Group 2 is higher than in Group 1, $288,827.90 and $145,911.70 Mexican pesos respectively (p=0.00578).

  Conclusions: The direct cost of medical attention is higher in the advanced stages compared to the early stages.